Rivarospire 2.5 Mg

Rivarospire 2.5 mg

Description:

Rivarospire 2.5 mg film-coated tablets is a prescription oral anticoagulant medicine containing rivaroxaban, a direct factor Xa inhibitor. It is used to prevent and treat formation of harmful blood clots in veins and arteries, and to reduce the risk of stroke and systemic embolism in specific high‑risk patients. By selectively blocking factor Xa in the coagulation cascade, Rivarospire 2.5 mg helps maintain smoother blood flow and lowers the risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and certain cardiovascular events when used under medical supervision.

Indications:

• Prevention and treatment of blood clots (venous thromboembolism) in eligible adult patients, as prescribed by a physician.
• Treatment and secondary prevention of deep vein thrombosis (DVT), which may cause leg pain, swelling, and redness.
• Treatment and secondary prevention of pulmonary embolism (PE), a blood clot in the lungs that can cause chest pain, shortness of breath, and rapid heartbeat.
• Reduction of the risk of stroke and serious blood clots in certain patients with non‑valvular atrial fibrillation, as directed by a cardiologist or specialist.
• Prevention of recurrent thromboembolic events in patients with a history of DVT or PE, according to physician assessment.
• Use as part of cardiovascular risk reduction strategies in selected high‑risk patients, when recommended by a healthcare professional.

Active Ingredients / Key Components:

• Rivaroxaban – 2.5 mg per film‑coated tablet (direct factor Xa inhibitor anticoagulant).
• Excipients: Film‑coating and tablet core excipients (such as fillers, binders, and colorants) are present but the full list and exact concentrations , please check the product leaflet or the manufacturer’s official website. Refer to the official package leaflet for complete excipient details.

Dosage & Administration / How to Use:

• Use Rivarospire 2.5 mg exactly as prescribed by your physician. Do not change your dose or stop the medicine without medical advice.
• Typical adult dosing regimens for rivaroxaban vary depending on indication (for example, DVT/PE treatment, prevention of recurrence, or stroke prevention in atrial fibrillation). The exact dose, frequency, and duration must be determined by the treating doctor. Specific dosing information for Rivarospire 2.5 mg for each indication is not provided in the available data and must be taken from the official prescribing information.
• Tablets are usually taken orally with water. They may be taken with or without food unless your doctor advises otherwise. For some higher rivaroxaban doses, intake with food is recommended; follow your doctor’s instructions for this 2.5 mg strength.
• Take the tablet at the same time(s) each day to maintain consistent blood levels.
• If you miss a dose, take it as soon as you remember on the same day, then continue with your regular schedule. Do not take a double dose to make up for a missed one. For precise missed‑dose instructions for your regimen, consult your physician or pharmacist.
• In case of planned surgery, dental procedures, or invasive interventions, inform your doctor and dentist that you are taking rivaroxaban. Your doctor may need to temporarily adjust or interrupt treatment.
• Do not crush or chew the tablet unless your healthcare provider specifically instructs you how to take it in patients with swallowing difficulties.

Clinical Benefits:

• Helps prevent formation of dangerous blood clots in veins and arteries by selectively inhibiting factor Xa in the coagulation pathway.
• Reduces the risk of stroke and systemic embolism in eligible patients with non‑valvular atrial fibrillation when used as prescribed.
• Treats and helps prevent recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE), supporting long‑term vascular health.
• Provides a fixed‑dose oral alternative to traditional anticoagulants, eliminating the need for routine INR monitoring in most patients, as directed by a physician.
• Offers predictable anticoagulant effect with appropriate dosing, contributing to more stable anticoagulation control when used correctly.

Warnings & Contraindications:

• Rivarospire 2.5 mg is a potent anticoagulant and may increase the risk of bleeding, which can be serious or life‑threatening. Use only under medical supervision.
• Contraindicated in patients with active clinically significant bleeding.
• Generally contraindicated in patients with severe hepatic impairment associated with coagulopathy and clinically relevant bleeding risk. Use with caution in any liver disease; dose adjustment or alternative therapy may be required.
• Use with caution in patients with renal impairment, especially moderate to severe kidney dysfunction. Your doctor may adjust the dose or select a different therapy.
• Not recommended in patients with prosthetic heart valves or certain types of valvular heart disease unless specifically advised by a specialist.
• Concomitant use with other anticoagulants (e.g., heparin, warfarin), antiplatelet agents (e.g., aspirin, clopidogrel), NSAIDs, or selective serotonin reuptake inhibitors (SSRIs) may increase bleeding risk. Inform your doctor about all medicines and supplements you are taking.
• Use with caution in patients with a history of gastrointestinal ulcers, recent brain or spinal surgery, recent major surgery or trauma, or conditions with increased bleeding risk.
• Consult your doctor before use if pregnant, planning pregnancy, or nursing. Anticoagulant therapy during pregnancy and breastfeeding requires careful risk‑benefit assessment.
• Inform your doctor if you have liver disease, kidney disease, uncontrolled high blood pressure, bleeding disorders, recent stroke, or if you are taking medicines that affect blood clotting.
• Do not stop taking Rivarospire 2.5 mg suddenly without medical advice, as this may increase your risk of blood clots, stroke, or other serious events.
• Avoid activities with high risk of injury or trauma that could lead to bleeding. Use caution with sharp objects and contact sports.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects may include easy bruising, nosebleeds, bleeding gums, heavier or prolonged menstrual bleeding, or minor bleeding from cuts that may take longer to stop.
• Other possible effects include anemia (low red blood cell count), headache, dizziness, weakness, or gastrointestinal symptoms such as stomach pain, indigestion, nausea, or vomiting.
• Serious side effects can include severe or uncontrollable bleeding, blood in urine or stools, black or tarry stools, coughing or vomiting blood, severe headache, sudden weakness or numbness, vision changes, difficulty speaking, or signs of stroke or internal bleeding.
• Allergic reactions (rare) may present as rash, itching, swelling of the face, lips, tongue, or throat, severe dizziness, or difficulty breathing. Seek immediate medical attention if these occur.
• Stop the medication and seek urgent medical help if you experience any signs of severe bleeding, sudden severe headache, confusion, chest pain, shortness of breath, or any symptom that feels life‑threatening.
• This is not a complete list of side effects. For full safety information, consult your doctor, pharmacist, or the official patient information leaflet.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Strength: 2.5 mg rivaroxaban per film‑coated tablet.
• Form: Film‑coated tablets for oral use.
• Pack size: 20 film‑coated tablets per pack (20 f.c. tabs).
• Intended use: Prescription anticoagulant medicine for adults, as directed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.